Arginase - 1 - Based Diagnosis as Indicator of the Risk of HBV - Related HCC

authors:

avatar Bita Moudi 1 , 2 , *

Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

how to cite: Moudi B. Arginase - 1 - Based Diagnosis as Indicator of the Risk of HBV - Related HCC. Gene Cell Tissue. 2018;5(1):e79725. https://doi.org/10.5812/gct.79725.

References

  • 1.

    Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Alavian SM, Lankarani KB, Farrokh P, et al. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity. Eur J Histochem. 2018;62(1):2859. [PubMed ID: 29569872]. [PubMed Central ID: PMC5806503]. https://doi.org/10.4081/ejh.2018.2859.

  • 2.

    Li H, Wang S, Wang G, Zhang Z, Wu X, Zhang T, et al. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation. Dig Surg. 2014;31(6):468-78. [PubMed ID: 25632982]. https://doi.org/10.1159/000370252.

  • 3.

    El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-76. [PubMed ID: 17570226]. https://doi.org/10.1053/j.gastro.2007.04.061.

  • 4.

    Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H. Impact of host gene polymorphisms on susceptibility to chronic hepatitis B virus infection. Infect Genet Evol. 2016;44:94-105. [PubMed ID: 27346643]. https://doi.org/10.1016/j.meegid.2016.06.043.

  • 5.

    Tawada A, Kanda T, Yokosuka O. Current and future directions for treating hepatitis B virus infection. World J Hepatol. 2015;7(11):1541-52. [PubMed ID: 26085913]. [PubMed Central ID: PMC4462692]. https://doi.org/10.4254/wjh.v7.i11.1541.

  • 6.

    Sekine S, Ogawa R, McManus MT, Kanai Y, Hebrok M. Dicer is required for proper liver zonation. J Pathol. 2009;219(3):365-72. [PubMed ID: 19718708]. https://doi.org/10.1002/path.2606.

  • 7.

    Multhaupt H, Fritz P, Schumacher K. Immunohistochemical localisation of arginase in human liver using monoclonal antibodies against human liver arginase. Histochemistry. 1987;87(5):465-70. [PubMed ID: 3323144].

  • 8.

    Chrzanowska A, Gajewska B, Baranczyk-Kuzma A. Arginase isoenzymes in human cirrhotic liver. Acta Biochim Pol. 2009;56(3):465-9. [PubMed ID: 19636440].

  • 9.

    Yan BC, Gong C, Song J, Krausz T, Tretiakova M, Hyjek E, et al. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol. 2010;34(8):1147-54. [PubMed ID: 20661013]. [PubMed Central ID: PMC3160135]. https://doi.org/10.1097/PAS.0b013e3181e5dffa.

  • 10.

    Timek DT, Shi J, Liu H, Lin F. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. Am J Clin Pathol. 2012;138(2):203-10. [PubMed ID: 22904131]. https://doi.org/10.1309/AJCPK1ZC9WNHCCMU.